Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice
Objective: Long-term glucocorticoids (GCs) therapy usually causes many metabolic side effects, including fatty liver. However, the molecular mechanisms remain poorly understood. Herein, we explored the molecular basis of GCs in the development of fatty liver. Methods: C57BL/6 male mice were injected...
Main Authors: | Jian Wan, Yi Shan, Xi Song, Song Chen, Xinyuan Lu, Jie Jin, Qing Su, Bin Liu, Wanju Sun, Bo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877819309305 |
Similar Items
-
Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
by: Bengmark Stig, et al.
Published: (2010-05-01) -
Ceramides: Nutrient Signals that Drive Hepatosteatosis
by: Scott A. Summers
Published: (2020-01-01) -
The relationship between vitamin D level and hepatosteatosis in obese children
by: Fatma Dursun, et al.
Published: (2019-03-01) -
Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling
by: Jiejie Zhao, et al.
Published: (2018-07-01) -
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
by: Sigrid Jall, et al.
Published: (2017-05-01)